GlassScriptPhysician profile
Kevin Platt
NPI 1861520777
$10,280.25
in general payments reported to CMS, 2019-2025
36 companies · $3,255 in 2025
The $3,255 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $552 · 2022: $1,322 · 2023: $2,641 · 2024: $2,511 · 2025: $3,255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,843 · Education: $364 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,842.51 |
| Education | $363.62 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,334.09 | 2021-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Inspire Medical Systems, INC. | $1,006.33 | 2021-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $908.66 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Actelion Pharmaceuticals US, INC. | $843.74 | 2021-2025 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $827.89 | 2021-2025 | Ofev, Jascayd |
| Insmed, INC. | $656.56 | 2021-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $636.11 | 2022-2025 | Wakix |
| United Therapeutics Corporation | $508.91 | 2022-2025 | Tyvaso, Tyvaso |
| Avadel Cns Pharmaceuticals, LLC | $478.77 | 2024-2025 | Lumryz |
| Jazz Pharmaceuticals INC. | $316.05 | 2022-2025 | |
| Astellas Pharma US INC | $253.50 | 2023 | Cresemba |
| Takeda Pharmaceuticals U.S.A., INC. | $252.76 | 2021-2025 | Glassia |
| Zoll Respicardia, INC. | $238.71 | 2023-2025 | Remede System |
| Genzyme Corporation | $210.59 | 2023-2025 | |
| Mylan Specialty L.P. | $185.24 | 2022-2024 | Yupelri |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $183.55 | 2021-2025 | Dupixent |
| Electromed, INC. | $178.95 | 2023-2025 | Smartvest |
| Inogen, INC. | $176.31 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Axsome Therapeutics, INC. | $175.06 | 2023-2025 | Sunosi |
| Grifols USA, LLC | $160.53 | 2024-2025 | Prolastin-C Liquid |
| Amgen INC. | $126.50 | 2022-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $125.12 | 2022-2025 | Acthar |
| Fresenius USA Marketing, INC. | $84.93 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $64.35 | 2021-2025 | Winrevair |
| Vifor Pharma, INC. | $51.14 | 2021-2022 | |
| Baxter Healthcare | $47.62 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Novartis Pharmaceuticals Corporation | $36.21 | 2025 | |
| Idorsia Pharmaceuticals US INC | $31.52 | 2023 | Quviviq |
| Lilly USA, LLC | $30.68 | 2025 | Zepbound |
| Verona Pharma, INC. | $30.05 | 2025 | Ohtuvayre |
| Amag Pharmaceuticals, INC. | $26.17 | 2022 | |
| Fisher & Paykel Healthcare INC | $22.11 | 2023 | Fisher & Paykel Healthcare |
| Janssen Pharmaceuticals, INC | $21.84 | 2023 | Xarelto |
| Paratek Pharmaceuticals, INC. | $18.22 | 2024 | Nuzyra |
| Philips North America LLC | $15.77 | 2022 | |
| Viatris Specialty LLC | $15.71 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.